The Fas molecule mediates apoptotic signal In many cell types. Mouse mutations (Ipr, Ipr^, glcf), which impair the function of Fas, cause spontaneous autoimmune disease. We generated Fasdeficient (Fas"'") mice by homologous recombination. In embryonic stem cells Fas"'" mice developed /pr-llke disease, confirming that the abnormality of Fas Is causal in the Ipr phenotype. We also made Fas" 7 " chimerlc mice composed of a mixture of Fas +/+ and Fas"'" cells. The chlmerlc mice also showed the Ipr phenotype. In Fas"'" chimeric mice, the Fas-deflclent population expanded progressively among mature T and B lymphocytes. The expansion of Fas-deficient lymphocytes occurred at the naive, pre-prlmed, lymphocyte stage. These results suggest that the Fas molecule functions not only after antlgenlc stimulation, as previously hypothesized, but also at the naive lymphocyte stage.
Introduction
Fas/Apo-1 (CD95) was originally discovered as a transmembrane protein which mediated an apoptotic signal (1-4) Ipr mice, which show lymphoproliferative disease characterized by massive enlargement of lymph nodes and hypergammaglobulinemia, express reduced amounts of Fas molecule due to the insertion of a transposable element into the Fas locus (5) (6) (7) (8) (9) . lpr°9 mice and gld mice develop lymphoproliferative disease similar to Ipr m\ce, and have point mutations in the genes encoding for Fas and Fas ligand respectively (6, (10) (11) (12) (13) .
Antigenic stimulation enhances the expression of Fas on lymphocytes. Several days after stimulation, lymphocytes become sensitive to Fas-mediated cell death (14) (15) (16) (17) (18) (19) (20) (21) . Activation-induced death of lymphocytes is impaired in .Ipr mice, and it is hypothesized that the major role of Fas is to cause cell death of activated lymphocytes and appropriately terminate the immune response (22) (23) (24) (25) (26) (27) .
We generated mice totally lacking Fas by homologous recombination in embryonic stem (ES) cells. By injecting
Generation of Fas +/~ and Fas^' ES clones
Transfection and screening of E14 ES cells were performed as described previously (29) . E14 ES cells were transfected with targeting vector, pFKO-Neo, to make Fas +/ " ES clones. For screening of pFKO-Neo-targeted clones by PCR, a Fasflanking primer, Fl (5'-CTTGTCCTGGCATTCCCCTACACT-3'), and a PGK-promoter-specific primer (5'-TGCTAAAGC-CCATGCTCCAGACTG-3') were used. Fas +/ " ES cells were further transfected with targeting vector, pFKO-Hyg, to make Fas"'" ES cell clones. For screening of pFKO-Hyg-targeted clones, primer Fl and poly(A)-fragment-specific primer (5'-GGTGGGGTGGGATTA-GATAAATGC-3') were used. PCR positive clones were analyzed by Southern blot hybridization to verify for homologous recombination (Fig. 1B) .
ES cells were microinjected into C57BL/6 (B6) blastocysts Injected blastocysts were implanted into uteri of pseudopregnant ICR mice to generate chimeric mice.
Genotyping of mice
Tail DNA was analyzed by PCR amplification to determine the genotype in the Fas locus Neomycin-resistance-genespecific primers (5'-ATTCGGCTATGACTGGGCACAACA-3' and 5'-CAGGAGCAAGGTGAGATGACAGG-3') were used to detect pFKO-Neo-targeted allele. Wild-type allele was detected by PCR amplification of a 0.2 kb fragment in the last exon of the Fas gene, using. PCR primers (5'-GAAGGACCTTGGAAAATCAACC-3' and 5'-TCTCAGCAACT-GCAGAGAATAAC-3')
Flow cytometry analysis
The following mAb conjugated with FITC, phycoerythrin (PE) or biotin were purchased from PharMingen (San Diego, CA) and used to stain cells: anti-CD4 (RM4-5), anti-CD8a (5-6.7), anti-B220 (RA3-6B2), anti-Ly-9.1 (30C7), anti-TCRo# (H57-597) and anti-CD62L (MEL-14). PE-conjugated goat antimouse IgM polyclonal antibody, anti-lgD (SBA1) mAb, and anti-CD44 (KM201) mAb were purchased from Southern Biotechnology Associates (Birmingham, AL). Red613-streptavidin (Gibco/BRL, Grand Island, NY) was used to reveal the biotin-conjugated mAb. Stained cells were analyzed on FACScan flow cytometer with CELLQuest software (Becton Dickinson, Mountain View, CA). Viable lymphocytes were gated according to forward and side scatter and propidium iodide staining. In some analysis, to purify T cells, lymph node cell samples were incubated with rat anti-mouse B220 (RA3-6B2) mAb, washed and mixed with Dynabeads (Dynal) coated with sheep anti-rat IgG. Unbound cells were recovered by using a magnetic separator (Advanced Magnetics). After purification twice with Dynabeads, purity of the recovered cell population was established by flow cytometric analysis and was always >96% TCRaP + T cells. 
ELISA

Results
Germlme-transmitted Fas~^~ mice develop the Ipr phenotype
Using the targeting vector, pFKO-Neo, for homologous recombination, the Fas gene was deleted except for exon 1, which encodes half of the signal peptide ( Fig. 1 " F 2 mice were obtained Absence of the Fas molecule in Fas"'" mice was confirmed by flow cytometric analysis ( Fig. 2A) .
We observed progressive enlargement of lymph nodes and spleens in Fas" " chimeric mice and control chimeric mice respectively) In Fas" 7 " chimeric mice, the ES-denved population is Fas"'" and the blastocyst-derived population is Fas +/+ . In control chimeric mice, both the ES-denved and blastocyst-derived population are Fas +/+ . Among the lymphocytes of chimeric mice, we identified ES-derived lymphocytes by an allotypic marker Ly-9.1, which is expressed on the cell surface of 129 (Ly-9.1) but not B6 (Ly-9.2) lymphocytes (29) . As expected, both Ly-9.1 + (ES-denved) and Ly-9.1" (blastocyst-derived) thymocytes of control chimeric mice expressed the Fas molecule. On the other hand, Ly-9.1 + thymocytes of Fas"'" chimeric mice did not express the Fas molecule (Fig. 4A) .
We observed progressive lymphadenopathy and splenomegaly (Fig. 3) , appearance of atypical lymphocytes (Fig.   4B ), hypergammaglobulinemia and production of anti-DNA antibody (Fig. 4C) in Fas"'" chimeric mice, but not in control chimeric mice. In brief, Fas"'" chimeric mice also developed Ipr syndrome.
Atypical CD4"CD8-TCR + B220 + lymphocytes in Fas"'" chimeric mice were exclusively Ly-9.1 + , indicating that they Age-dependent expansion of Fas''' lymphocytes in (31, 32) , enlarged peripheral lymphoid organs of Fas"'" chimeric mice chimeric mice contained conventional CD4 + , CD8 + and lgM + lymphocytes in addition to the atypical lymphocytes (Fig. 4B) . We examined the age-dependent change of the ES-derived Relative Ly-9.1*/Ly-9.r Rg. 5. Progressive expansion of Fas"'" population among peripheral blood T and B lymphocytes in chimeric mice Tail blood samples were obtained from chimeric mice at 3, 8 and 12 weeks. The Ly-9 1 + :Ly-9 1" ratio in peripheral blood T and B cell populations was determined, based on two-color flow cytometric analysis The agedependent change of the Ly-9.1 + :Ly-9 1" ratio in each mouse was evaluated by the relative ratio calculated as described in the text. TCRaP + cells were defined as T lymphocytes and B220 + cells were defined as B lymphocytes at 3 weeks. CD4
+ and CD8 + cells were defined as T lymphocytes and lgM + cells were defined as B lymphocytes at 8 and 12 weeks. The average values and SD (error bars) of Fas"'" chimeric mice (n = 10) and control chimeric mice (n = 5) are shown. Relative Ly-9.1*/Ly-9.i" 
A function of the Fas molecule on mature lymphocytes
To determine the differentiation stage at which the Fas"'" lymphocyte population expands, we analyzed the Ly-9.1 + .Ly-9.1" ratio in T and B lymphocytes in thymi, spleens, lymph nodes, and bone marrow of 8-week-old chimeric mice.
We calculated the relative Ly-9 1 + Ly-9 1" ratio for T cell lineage as (ratio in a specific population of T cell lineage).(ratio in TCR 10 " thymocyte population) for each mouse As shown in Fig. 6(A) , the relative ratio in the TCR h ' 9h thymocyte population in Fas"'" chimeras was not different from that in control chimeras. On the other hand, in mature T cell populations in lymph nodes and spleens, the relative ratio in Fas"'" chimeras was higher than that in control chimera
We calculated the relative Ly-9.1 + :Ly-9.1" ratio for B cell lineage as (ratio in a specific population of B cell lineage):(ratio in B220 + IgM" bone marrow cell population) for each mouse. As shown in Fig. 6(B) , the relative ratio in B220 + lgM + bone marrow cell population in Fas"'" chimeras was not different from that in control chimera. On the other hand, in the populations of lgD + mature B cells in spleens and lymph + .Ly-9.1" ratio was determined in thymocytes and in CD62L h| 9 h , CD62L k)w , CD44 hl 8 h and CD44 low lymph node T cell populations, based on two-color flow cytometric analysis T lymphocytes purified from lymph nodes of 5-week-old chimeric mice were analyzed. The relative ratio was calculated as described in the text. The average values and SD (error bars) of Fas"'" {n = 5) and control (n = 9) chimeric mice are shown nodes, the relative ratio in Fas"' chimeras was higher than that in control chimera.
More than 80% of lymphocytes were of conventional phenotype (CD4 + , CD8 + or lgM + ) in 8-week-old Fas^" chimeric mice, whose lymph nodes contained at least six times as many lymphocytes as control chimeric mice in the case that coat-color-chimerism was 70% or more. Therefore, Fas"'" lymphocytes increased not only relatively to Fas +/+ lymphocytes but also in absolute number.
Taken together, the Fas" 7 " population abnormally increased in mature T and B lymphocytes in peripheral lymphoid organs, but not in thymus or bone marrow. These results suggest that Fas functions at the mature lymphocyte stage, although we cannot rule out that Fas has a function also at the immature stages
Functional significance of the Fas molecule in naive lymphocytes
Because lgD + B cells are at the naive or pre-pnmed stage (33), the result described above that the Fas"'" population increased among lgD + B lymphocytes indicates an abnormal increase of Fas"'" naive B cells. Therefore, in normal situations, the Fas molecule functions to regulate the number of naive B cells.
We examined whether Fas has a regulatory role also in naive T cells. To avoid the complexity in flow cytometric analysis due to the existence of atypical lymphocytes, we analyzed 5-week-old chimeric mice, in which atypical lymphocytes were <4% of total lymph node cells of Fas"'" chimeric mice High expression of CD62L (L-selectin) and low expression of CD44 (Pgp-1) are markers for naive lymphocytes (34) (35) (36) (37) . We calculated the relative Ly-9 1 + :Ly-9.1" ratio for lymph node T cell populations classified according to the level of expression of CD62L and CD44, by the same formula as described above. In both CD62L h| 9 h and CD62L low as well as both CD44 h| 9 h and CD44 low T cell populations, the relative ratio in Fas"'" chimeric mice was higher than that in control chimeric mice (Fig. 7) Thus, the unregulated increase of Fas"'" T cell occurred before the differentiation to memory cells, suggesting that Fas plays a regulatory role in naive T cells.
Discussion
The genomic region encoding mature Fas protein was completely deleted by the targeting constructs which span at least 30 kb. Although we have not obtained contiguous DNA clones covering all the deleted region, the deletion may be >50 kb, based on the report that the mouse Fas gene consists of >70 kb (7) .
Not only germline-transmitted Fas"'" mice but also Fas"'" chimeric mice showed the Ipr phenotype These results are consistent with a report on allophenic chimeras developed from Ipr/lpr and +/+ embryos (38) On the other hand, bone marrow chimeras, irradiated +/+ mice implanted with Ipr/lpr bone marrow grafts, did not show the Ipr phenotype but showed graft-versus-host-disease-like syndrome and atrophy of lymphoid organs (39) (40) (41) . The difference between embryonic chimeras and bone marrow chimeras is that Fas" non-bone-marrow-derived cells exist in embryonic chimeras, but not in bone marrow chimeras'. Therefore, the existence of Fas" non-bone-marrow-derived cells, probably stromal cells in lymph node and spleen, may be a requisite for lymphoproliferation of Ipr mice This explanation is supported by the report of Matsuzawa et al (42) that Ipr/lpr bone marrow grafts caused enlargement of simultaneously implanted lymph nodes derived from Ipr/lpr mice but not those derived from +/+ mice.
From the data shown in Figs 6 or 7, we cannot rule out that Fas has a function on immature cells which manifests itself in more mature cells. However, an age-dependent increase of the discrepancy of Ly-9.1 + :Ly-9.1" ratio between the mature and immature populations supports the notion that Fas functions at the mature lymphocyte stage. In 2-week-old chimeric mice, there was no effect of the absence of Fas on the discrepancy in the Ly-9.1 + .Ly-9.1" ratio between mature and immature populations (data not shown). On the other hand, we observed a progressively increasing discrepancy in older Fas"'" chimeric mice (Figs 6 and 7, and data not shown). These results suggest that mature lymphocytes, probably self-renewing, may accumulate in peripheral lymphoid organs when they are Fas-deficient, although a possibility still remains that the effect of Fas on immature cells increases in an agedependent manner.
There are many reports that Fas is involved in activationinduced lymphocyte cell death (19) (20) (21) (22) (23) (24) (25) (26) . It is hypothesized that the major role of Fas in lymphoid systems is to kill activated lymphocytes and terminate the immune response. The current idea is that the failure of Fas-mediated death of activated lymphocytes causes abnormal lymphoproliferation in Ipr and gld mice (43) . However, there is no evidence directly connecting the impairment of activation-induced cell death with lymphoproliferation and autoimmune disease of /p/rnice In our in vitro experiment, TCR-mediated stimulation caused cell death even in Fas"'" T cells, although the rate of death was lower than that in Fas +/+ T cells (unpublished observation). Thus, activation-induced cell death does not totally depend on Fas.
In the Fas"'" chimeric mice, the Fas"'" population expanded in the naive T and B lymphocytes, suggesting that the Fas molecule plays a regulatory role in lymphocytes even before they are stimulated with exogenous antigen. In agreement with this role, the Fas molecule is expressed on most of the mature T lymphocytes (most of them are naive T cells) and >20% of lgD + B lymphocytes in normal mice (data not shown). Our results are supported by data from Sidman et al. (44) , who reported that T lymphocytes bearing male-antigenspecific TCR participated in the lymphoproliferative process even in female Ipr or gld mice. Their results imply that interactions with specific antigen are not necessary for abnormal proliferation of Fas-deficient lymphocytes. Ettinger et al. observed that autoreactive T lymphocytes existed mainly in the naive T cell fraction of Ipr mice (45) We propose that, in addition to the failure of activation-induced cell death, the impairment of function of Fas in naive lymphocytes also contributes to the development of lymphoproliferation and autoimmune disease
